Microbiome Interactions in Health and Disease

Microbiome Interactions in Health and Disease 24 October, 2022 - 26 October, 2022

Wellcome Genome Campus, Hinxton, CB10 1RQ, UK

Web Address



Deadline: 27/09/2022
Click here to register

Submit your abstract here

General Information

This conference will be a hybrid meeting – with onsite or virtual attendance.

6 Sept 2022 (abstract deadline)
27 Sept 2022 (in person registration deadline)
17 Oct 2022 (virtual registration deadline

Programme committee
Lindsay Hall – Technical University of Munich, Germany
Reetta Satokari – University of Helsinki, Finland
Alan Walker – University of Aberdeen, UK
Jerry Wells- Wageningen University & Research, The Netherlands

The 11th Microbiome Interactions in Health and Disease meeting will bring together leading scientists and clinicians from the fields of microbiology, gastroenterology, nutrition, cancer and public health to discuss the latest developments in this fast-moving area.
This year’s meeting will focus on cancer–microbiome interactions and the influence of the diet and nutrition on the microbiota that live in our digestive system. We will also discuss how viruses affecting respiratory health, including SARS-COV-2, can affect the microbiome, as well as the lessons learned on microbiome manipulation from the wider animal kingdom.

Topics will include:
• Microbiome and cancer
• Respiratory health, microbiome and the age of Covid
• Nutrition, metabolism and the microbiome
• Methological and modelling innovations
• Beyond bacteria
• Exploring the microbiome – lessons from the animal kingdom

Deadline for submissions: 6 Sept 2022 (abstract deadline)

Meeting organisers:

Wellcome Connecting Science




Keynote speakers

Ruth Ley – Max Planck Institute for Developmental Biology, Germany

Eran Segal – Weizmann Institute, Israel


Confirmed speakers

Amy Apprill – Woods Hole Oceanographic Institution, USA

Leah Cuthbertson – Imperial College London, UK

Sabina Leanti La Rosa – Norwegian University of Life Sciences, Norway

Spencer Diamond – University of California, Berkeley, USA

Sonia Fernandez-Veledo – University Hospital of Tarragona Joan XXIII – Pere Virgili Health Research Institute – CIBERDEM, Spain

Marnix Medema – Wageningen University, The Netherlands

Christine Moissl-Eichinger – Medical University of Graz, Austria

Imke Mulder – 4D Pharma, UK

Stephen Robinson – Quadram Institute Bioscience, UK

Andrey Shkoporov – APC Microbiome, Ireland

Erika von Mutius – Ludwig Maximilian University of Munich, Germany